ANDA 84468, held by Barr Laboratories. Brompheniramine Maleate.
As of Nov 21, 2026, ANDA 84468 (Brompheniramine Maleate), held by Barr Laboratories, was first approved by FDA on Apr 7, 1975, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 7, 1975 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Brompheniramine Maleate4MG · tablet;oral | Brompheniramine Maleate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters